| 1 |
extended-spectrum beta-lactamase
(4615 times)
|
Microbiology
(1256 times)
|
MDR (324 times)
MRSA (241 times)
PFGE (216 times)
|
1992 Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime.
|
| 2 |
extended beta-lactamase
(7 times)
|
Communicable Diseases
(2 times)
|
CF (1 time)
DD (1 time)
DDST (1 time)
|
2008 Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
|
| 3 |
ESBL and AmpC-beta-lactamase
(3 times)
|
Communicable Diseases
(1 time)
|
ESBL-PE (2 times)
OPD (1 time)
|
2020 Carriage of Extended-Spectrum-beta-Lactamase- and AmpC-beta-Lactamase-Producing Enterobacteriaceae (ESBL-PE) in Healthy Community and Outpatient Department (OPD) Patients in Nepal.
|
| 4 |
exo-small beta-lactamase
(2 times)
|
Biophysics
(1 time)
|
---
|
2007 Effects of serine-to-cysteine mutations on beta-lactamase folding.
|
| 5 |
Extended Spectrum Beta-Lactamase-producing E. coli
(2 times)
|
Communicable Diseases
(2 times)
|
MRSA (1 time)
Mtb (1 time)
UVC (1 time)
|
2017 Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics.
|
| 6 |
extended spectrum betalactamase-producing gram-negative bacteria
(2 times)
|
Rehabilitation
(2 times)
|
MRSA (3 times)
MDRO (2 times)
|
2015 [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main-District, Germany, 2014: Prevalence and Risk Factors].
|
| 7 |
extended-spectrum beta-lactamase-producing organisms
(2 times)
|
Medicine
(1 time)
|
CI (1 time)
CRE (1 time)
LTACs (1 time)
|
2010 Recognition and management of extended spectrum beta lactamase producing organisms (ESBL).
|
| 8 |
Extended-Spectrum BLs
(2 times)
|
Natural Science Disciplines
(1 time)
|
BLI (2 times)
BLs (2 times)
BA (1 time)
|
2017 Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-beta-lactamases.
|
| 9 |
CTX-M-type-extended-spectrum beta-lactamase
(1 time)
|
Drug Therapy
(1 time)
|
PFGE (1 time)
|
2020 Characterization of CTX-M-type-extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from Indonesian undergraduate medical students of a university in Surabaya, Indonesia.
|
| 10 |
encoding clinically important carbapenemases as well as selected extended
(1 time)
|
Medicine
(1 time)
|
---
|
2014 Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay.
|
| 11 |
enterobacteria produced by beta lactamase were recorded
(1 time)
|
General Surgery
(1 time)
|
CDC (1 time)
CNS (1 time)
NI (1 time)
|
2009 [Results of epidemiological surveillance of hospital infections at the Clinic of Digestive System Surgery, CCS, in 2007].
|
| 12 |
ESBL producer with identical bla
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2012 Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.
|
| 13 |
ESBL, except when bla
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
TEM (1 time)
|
2005 Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain.
|
| 14 |
ESBL-producing, fosfomycin-resistant E. coli. bla
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
ESBLs (1 time)
|
2009 CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
|
| 15 |
ESBLs and by sequencing of bla
(1 time)
|
Medicine
(1 time)
|
PFGE (1 time)
UPEC (1 time)
|
2012 Characterization of the extended-spectrum beta-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children.
|
| 16 |
ESBLs were characterized by PCR and sequencing of bla
(1 time)
|
Drug Therapy
(1 time)
|
PFGE (1 time)
|
2010 Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
|
| 17 |
established by PFGE and multilocus sequence typing (MLST). bla
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
MLST (1 time)
|
2009 Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults.
|
| 18 |
ester of CBL
(1 time)
|
Neoplasms
(1 time)
|
BC (1 time)
CBL (1 time)
ERalpha (1 time)
|
2005 The effect of an estrone D-lactam steroid ester derivative on breast cancer cells and its predicted binding interactions with the ligand binding domain of estrogen receptor-alpha.
|
| 19 |
EUCAST guidelines were followed for antibiotic susceptibility testing, and bla
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
ESBL-EC (1 time)
UTIs (1 time)
|
2010 Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.
|
| 20 |
Extended spectrum beta lactamase forming pathogens
(1 time)
|
Medicine
(1 time)
|
---
|
2012 [Extended spectrum beta lactamase forming pathogens (ESBL)].
|
| 21 |
extended-spectrum beta-lactamase Escherichia coli
(1 time)
|
Endoscopy, Digestive System
(1 time)
|
ERCP (1 time)
|
2014 Fatal Cerebral Air Embolism Due to a Patent Foramen Ovale during Endoscopic Retrograde Cholangiopancreatography.
|
| 22 |
extended-spectrum beta-lactamase-producing Klebsiella pneumoniae
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
---
|
2009 Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
|
| 23 |
extended-spectrum producing beta-lactamase
(1 time)
|
Communicable Diseases
(1 time)
|
PICU (1 time)
|
2010 Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit.
|
| 24 |
plasmid-coded broad-spectrum Beta-lactamases
(1 time)
|
Communicable Diseases
(1 time)
|
OMP (1 time)
|
2006 [Development of Beta-lactamase resistance in enterobacteria].
|
| 25 |
plasmid-mediated-extended-spectrum-beta-lactamase
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2003 Plasmid-mediated extended-spectrum beta-lactamase-producing strains of Enterobacteriaceae isolated from diabetes foot infections in a Brazilian diabetic center.
|
| 26 |
well-established methods for screening and confirmation of class A
(1 time)
|
Microbiology
(1 time)
|
3-APB (1 time)
BA (1 time)
M3DT (1 time)
|
2012 [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
|
A Search Service for Abbreviation / Long Form